AnHeart Therapeutics
Hangzhou
About AnHeart Therapeutics
AnHeart Therapeutics is a developer of innovative pharmaceutical products. The company is focused on acquiring, developing and commercializing innovative pharmaceutical products that improve human health and quality of life. It's main research product, AB-106, is an oral, highly selective ROS1/NTRK small molecule inhibitor.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $75.6M
- Funding stage: M&A
- Last round: Series B (Dec 2021)
- Website: anhearttherapeutics.comenhome
- Phone: +(86)(0571) 5626-3086
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/anheart-therapeutics-38256 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.